Classic methodologies of drug discovery takes too long, costs too much and is too risky. We use sophisticated algorithms to find highly significant statistical correlations in Israel's high quality EMRs, to expose clinical effects retrospectively. Our competitive advantage comes from the quality (longevity and robustness) of Israeli clinical data, combined with cutting edge data science and a savvy, experienced pharma team with over 50 years of experience to drive a portfolio of new products.
Connect with Bloomsbury AI Ltd
